Log In
BCIQ
Print this Print this
 

a2b-413

Also known as: PEGylated dimeric IFN-a2b

  Manage Alerts
Collapse Summary General Information
Company Immunomedics Inc.
DescriptionInterferon (IFN)-a2b conjugated to 30 kDa polyethylene glycol (PEG)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationLymphoma
Indication DetailsTreat Burkitt's lymphoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today